The Risk of Anti-Selection in Protection Business from Advances in Statistical Genetics
Four-part webcast series presents new research and explores potential implications for the insurance industry.
Can Genetic Testing Improve Mortality Risk?
Genetic testing is now available for many disorders. We have known for centuries that heredity is involved in many diseases. However, 15 years ago the Human Genome project was completed, and the sequence of human DNA is now known. This major accomplishment has caused an explosion of new information about genetic diseases, confirming previous suspicions in many diseases and identifying the genetic contribution in others.
Be Kind to Your Genes: An Insurance Perspective on the Fast-Growing Field of Epigenetics
Eat your vegetables. Stay active. Avoid smoking. Keep out of the sun. Patients have been hearing this good advice from their doctors for a long time. Now, researchers are uncovering new evidence that our lifestyle choices can measurably influence mortality risk at a genetic level. Learn more about the emerging science of epigenetics in a two-part interview and the webinar “Epigenetics and Liquid Biopsies: Fact, Fiction or Both.”
Emerging Trends in Life Underwriting
There have been a number of changes in the insurance landscape in the recent past which present challenges for the consumer, advisor and underwriter. Last year, some carriers changed their position on marijuana usage by offering their clients non-smoker rates. There have also been recent legislative changes regarding genetic testing that impact life insurers.
How Will Genomics Impact Medical Underwriting?
Progress in genomics is creating opportunities and threats for medical underwriting in both health and life insurance.
Understanding the Genetics of Cancer
Complicated pathology reports can contain significant amounts of genetic information. It has become vital for insurance company medical directors, underwriters, and claims professionals to understand "driver mutations" present in, or absent from, a tumor's genome, well as targeted therapies and their mechanisms. This article will examine how genetics contributes to cancer development, treatment, and prognosis.
Consumers, Insurers and Genetic Information
The United Kingdom may have come up with a good, practical compromise.
Genetic Testing Could Cause Anti-selection But Also Have Positive Impact on In-Force Book
Christian Mumenthaler, CEO of Swiss Re, discusses the impact technology may have on longevity risk, and on the life re/insurance industry. Recorded at the 14th Global Ageing Conference in Zurich.
Genetic Testing – What Does the Crystal Ball Really Reveal?
Knowing the basics of genetic testing and its underlying science is the first step in understanding genetic testing’s potential impact on insurance. Genetic testing is best defined as the analysis of DNA, RNA, chromosomes, proteins and metabolites in relation to heritable risks, traits, and conditions.